Journal of the National Cancer Institute (JNCI) |
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer |
mai. 17 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project |
juin. 18 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer |
aoû. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer |
mai. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas |
Jan. 17 |
|
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Colorectal Cancer Incidence Patterns in the United States, 1974–2013 |
aoû. 17 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States |
déc. 18 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites |
juin. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers |
juil. 16 |
3 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac, Endoscopie/Imagerie |
Journal of the National Cancer Institute (JNCI) |
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma |
mai. 15 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer |
avr. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes |
aoû. 16 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome |
juin. 15 |
3 ♥ |
Cancer colorectal (CCR), Génétique |
Journal of the National Cancer Institute (JNCI) |
Coffee Consumption and Risk of Gallbladder Cancer in a Prospective Study |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy |
mai. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States |
mai. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma |
oct. 17 |
3 ♥ |
Carcinome hépatocellaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer |
mai. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis |
nov. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival. |
juil. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial |
nov. 15 |
1 ♥ |
Cancer colorectal (CCR) |